In pancreatic cancer, FNDC5 inhibited the growth of pancreatic cancer cells through the AMPK-mTOR pathway, and inhibited the migration and invasion of pancreatic cancer cells through the inhibition of EMT (Liu et al., 2018). Here, MTOR is linked to familial pancreatic carcinoma.